Format
Sort by

Send to

Choose Destination

Search results

Items: 5

  • Showing results for werdan jiang. Your search for Wendan Jiang retrieved no results.
1.

Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Schlitt A, Schwaab B, Fingscheidt K, Lackner KJ, Heine GH, Vogt A, Buerke M, Maegdefessel L, Raaz U, Werdan K, Jiang XC.

Lipids. 2010 Feb;45(2):129-35. doi: 10.1007/s11745-010-3384-5. Epub 2010 Jan 27.

PMID:
20108050
2.

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.

Schlitt A, Blankenberg S, Bickel C, Lackner KJ, Heine GH, Buerke M, Werdan K, Maegdefessel L, Raaz U, Rupprecht HJ, Munzel T, Jiang XC.

J Lipid Res. 2009 Apr;50(4):723-9. doi: 10.1194/jlr.M800414-JLR200. Epub 2008 Nov 10.

3.

Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.

Seiler S, Schlitt A, Jiang XC, Ulrich C, Blankenberg S, Lackner KJ, Girndt M, Werdan K, Buerke M, Fliser D, Heine GH.

Nephrol Dial Transplant. 2008 Nov;23(11):3599-604. doi: 10.1093/ndt/gfn296. Epub 2008 May 25.

PMID:
18503096
4.

Phospholipid transfer protein in hemodialysis patients.

Schlitt A, Heine GH, Jiang XC, Messow M, Blankenberg S, Rupprecht HJ, Ulrich C, Buerke M, Werdan K, Lackner KJ, Köhler H, Girndt M.

Am J Nephrol. 2007;27(2):138-43. Epub 2007 Feb 16.

PMID:
17308375
5.

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.

Schlitt A, Blankenberg S, Yan D, von Gizycki H, Buerke M, Werdan K, Bickel C, Lackner KJ, Meyer J, Rupprecht HJ, Jiang XC.

Nutr Metab (Lond). 2006 Jan 5;3:5.

Supplemental Content

Loading ...
Support Center